United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$159Mraised across 9 rounds since 2007, from 9 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $15M sold, first sale Jan 2015
No investor was named in the report.
From a historical funding recordSEC filing: $1.3M sold, first sale Dec 2014
No investor was named in the report.
From a historical funding record
From a historical funding record
No investor was named in the report.
Reported by sec.govSEC filing: $4.7M sold, first sale Apr 2011
No investor was named in the report.
Reported by sec.govSEC filing: $3.1M sold, first sale Aug 2010
No investor was named in the report.
Reported by sec.govSEC filing: $39M sold, first sale Jun 2009
Reported by onbiovc.com
Reported by zosanopharma.com
From the SEC filings it signed: 6 on the team.
On the board, as filediBruce D. SteelJohn WalkerJoseph P. HaganKleanthis D. XanthopoulosTroy D. Wilson
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
New Enterprise Associates
ProQuest InvestmentsBioMed VenturesMissing a round, or an investor who was in one? Tell us.
This firm lists Zosano Pharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Zosano Pharma's investors include New Enterprise Associates, Nomura, HBM BioVentures, ProQuest Investments and BioMed Ventures.
Zosano Pharma has raised $159M across 9 rounds since 2007.
Zosano Pharma's most recent round was an Undisclosed round of $15M in Feb 2015.
Zosano Pharma's largest round on record is $90M (Series A), in Nov 2007.
Zosano Pharma's first round on record, in Nov 2007, was backed by New Enterprise Associates, HBM BioVentures and ProQuest Investments and 1 others.
Zosano Pharma's latest named round is an Undisclosed round, in Feb 2015.
Zosano Pharma is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
